2020 Was The Year of Psychedelics — Here’s Why

While many 2020 memories will be gladly left behind, that’s not necessarily the case for psychedelics.

There was unprecedented renaissance as psychedelic compounds, and their potential to treat mental health conditions, became one of the centerpieces of this year’s public conversation. 

Psychedelic companies — those researching and producing these compounds — jumped into the spotlight of investment markets, with almost two dozen psychedelics companies going public between February and December.
Read More